Adeno-associated vector (type 8)-mediated expression of soluble Flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model.
about
A comprehensive review of retinal gene therapyAAV2 delivery of Flt23k intraceptors inhibits murine choroidal neovascularizationHorizons in therapy for corneal angiogenesis.Long-term efficacy of ciliary muscle gene transfer of three sFlt-1 variants in a rat model of laser-induced choroidal neovascularizationAAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2(-/-)/Cx3cr1(-/-) miceDevelopment of gene therapy for treatment of age-related macular degeneration.Augmented anti-angiogenesis activity of polysulfated heparin-endostatin and polyethylene glycol-endostatin in alkali burn-induced corneal ulcers in rabbitsAdvances in Gene Therapy for Diseases of the Eye.Neovascular age-related macular degeneration: opportunities for development of first-in-class biopharmaceuticals.Drugs in Phase II clinical trials for the treatment of age-related macular degeneration.Adeno-associated virus type 8 vector-mediated expression of siRNA targeting vascular endothelial growth factor efficiently inhibits neovascularization in a murine choroidal neovascularization modelCurrent advances in the treatment of neovascular age-related macular degeneration.Inhibitory effect of polysulfated heparin endostatin on alkali burn induced corneal neovascularization in rabbits.Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation.Adenoviral vector encoding soluble Flt-1 engineered human endometrial mesenchymal stem cells effectively regress endometriotic lesions in NOD/SCID mice.Reducible PEG-POD/DNA Nanoparticles for Gene Transfer In Vitro and In Vivo: Application in a Mouse Model of Age-Related Macular Degeneration.Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates.Direct comparison of administration routes for AAV8-mediated ocular gene therapy.
P2860
Q27023914-617ADD74-AC4F-4484-84FA-2C8492A0A531Q27318539-ACEB246C-7782-4D81-A5CC-D9641B9D57FBQ27691454-BEB283CD-8B32-48A6-92A4-9BFC20E58EC8Q28582445-B2C69940-758E-4317-A08C-C8CBC7C493F0Q35106359-C1D44E17-836D-40A8-B8A0-7165A9034AD5Q35192906-5CDACF57-B2E4-4040-BDB4-4C8C51B6E822Q35942802-2F28B426-8900-4999-A55A-C2206F11A5DAQ37190609-EBEB315C-459E-4F30-848C-71B72670DC51Q37882685-64D7A572-605E-4D96-8B6B-72AD7F2E427AQ38253067-0A2B301E-7C99-4596-B6B7-BDFD03364F99Q38714555-A42AD5B4-73D4-4FF0-AF23-994D5709877DQ38902191-B5CC2847-B90C-4327-B0E8-6D9549285DC4Q40049688-FCA3BF37-ACD9-4DEE-869F-75D70AED005CQ40640361-C5CC621A-3A2D-4F22-AEF4-ED31D47FFA7FQ40846016-306DB064-AD5F-4686-9856-E121A7C7C180Q40997212-5594A8B1-7A39-4B4C-87F5-81AB8145693AQ45874908-6E42740A-9650-4A54-8C00-8257ABE185FEQ45885693-27373EA1-614A-4EF9-9054-9615A37B3443
P2860
Adeno-associated vector (type 8)-mediated expression of soluble Flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Adeno-associated vector (type ...... idal neovascularization model.
@ast
Adeno-associated vector (type ...... idal neovascularization model.
@en
Adeno-associated vector
@nl
type
label
Adeno-associated vector (type ...... idal neovascularization model.
@ast
Adeno-associated vector (type ...... idal neovascularization model.
@en
Adeno-associated vector
@nl
prefLabel
Adeno-associated vector (type ...... idal neovascularization model.
@ast
Adeno-associated vector (type ...... idal neovascularization model.
@en
Adeno-associated vector
@nl
P2093
P356
P1433
P1476
Adeno-associated vector (type ...... idal neovascularization model.
@en
P2093
Hiroshi Takahashi
Ikuya Masuda
Koichi Miyake
Takashi Shimada
P304
P356
10.1089/HUM.2009.153
P577
2010-05-01T00:00:00Z